Literature DB >> 10768096

Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study.

B Karamanos1, M Porta, M Songini, Z Metelko, Z Kerenyi, G Tamas, R Rottiers, L K Stevens, J H Fuller.   

Abstract

AIMS/HYPOTHESIS: To identify factors associated with early development of and late protection from microvascular complications in subjects with Type I (insulin-dependent) diabetes mellitus.
METHODS: The frequency of microvascular complications and their relation to risk factors were studied in 300 Type I diabetic subjects with short duration of disease (< or = 5 years) compared with 1062 subjects with long duration (> or = 14 years). Microvascular disease was defined as the presence of either retinopathy (assessed from centrally-graded retinal photographs) or urinary albumin excretion rate of more than 20 micrograms/min.
RESULTS: The prevalence of microvascular disease was 25% in the short duration group. In the long duration group 18% had no evidence of microvascular complications. In the short duration group factors associated with early development of complications were cigarette smoking and a family history of hypertension. Subjects free of microvascular complications in spite of long duration of diabetes had better glycaemic control, lower blood pressure, better lipid profile and lower von Willebrand factor levels. CONCLUSION/
INTERPRETATION: At the early stages of Type I diabetes, cigarette smoking and genetic susceptibility to hypertension are important risk factors for microvascular complications. At a later stage, additional risk factors are poorer glycaemic control, higher blood pressure, and an unfavourable lipid profile possibly associated with endothelial dysfunction. Many of these factors are amenable to long-term intervention which should be started as soon as possible in the course of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10768096     DOI: 10.1007/s001250050053

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

Review 1.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

2.  Characteristics associated with neuropathy and/or retinopathy in a hospital outpatient diabetic clinic.

Authors:  Mary T McClean; William John Andrews; James C McElnay
Journal:  Pharm World Sci       Date:  2005-06

Review 3.  The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis.

Authors:  Xiaoling Cai; Yifei Chen; Wenjia Yang; Xueying Gao; Xueyao Han; Linong Ji
Journal:  Endocrine       Date:  2018-08-20       Impact factor: 3.633

Review 4.  Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Authors:  Merlin C Thomas; Robert C Atkins
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year follow up study.

Authors:  L Kessel; B Sander; P Dalgaard; M Larsen
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

6.  Renal functional reserve in patients with Type 1 diabetes mellitus.

Authors:  Jelka Zaletel; Darko Cerne; Katarina Lenart; Sabine Zitta; Günther Jürgens; Willibald Estelberger; Andreja Kocijancic
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

7.  Nicotine accelerates diabetes-induced retinal changes.

Authors:  Adam Boretsky; Praveena Gupta; Nima Tirgan; Rong Liu; Bernard F Godley; Wenbo Zhang; Ronald G Tilton; Massoud Motamedi
Journal:  Curr Eye Res       Date:  2014-06-09       Impact factor: 2.424

Review 8.  Epidemiological issues in diabetic retinopathy.

Authors:  Peter H Scanlon; Stephen J Aldington; Irene M Stratton
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

9.  Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.

Authors:  Zhale Rajavi; Sare Safi; Mohammad Ali Javadi; Mohsen Azarmina; Siamak Moradian; Morteza Entezari; Ramin Nourinia; Hamid Ahmadieh; Armin Shirvani; Saeid Shahraz; Alireza Ramezani; Mohammad Hossein Dehghan; Mohsen Shahsavari; Masoud Soheilian; Homayoun Nikkhah; Hossein Ziaei; Hasan Behboudi; Fereydoun Farrahi; Khalil Ghasemi Falavarjani; Mohammad Mehdi Parvaresh; Hamid Fesharaki; Majid Abrishami; Nasser Shoeibi; Mansour Rahimi; Alireza Javadzadeh; Reza Karkhaneh; Mohammad Riazi-Esfahani; Masoud Reza Manaviat; Alireza Maleki; Bahareh Kheiri; Faegheh Golbafian
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

10.  Body mass index and retinopathy in type 1 diabetic patients.

Authors:  Snježana Kaštelan; Jasminka Salopek Rabatić; Martina Tomić; Antonela Gverović Antunica; Spomenka Ljubić; Helena Kaštelan; Branko Novak; Darko Orešković
Journal:  Int J Endocrinol       Date:  2014-02-18       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.